Nav: Home

New tool to predict epileptic seizures in pregnancy could save lives

May 13, 2019

A new risk calculator for pregnant women with epilepsy, developed by researchers from Queen Mary University of London, has been found to accurately predict the risk of seizures during pregnancy and up to six weeks after delivery, and could save the lives of mothers and babies.

The EMPiRE tool has been made freely available online to help clinicians identify women at high risk of seizure, and inform their care through close monitoring and anti-epileptic drug management.

Women with epilepsy are ten-times more likely to die in pregnancy than those without the condition, with seizures as the main cause of death. It has been consistently highlighted that the main factor behind these deaths is a lack of recognition of the women's high-risk status by health professionals.

Pregnant women with epilepsy are advised not to alter their treatment without specialist advice. However, up to four in ten women discontinue their anti-epileptic medication in pregnancy due to concerns about the effects of drugs on the unborn baby, thereby increasing their risks of seizures.

Ngawai Moss, 38, has epilepsy, and is the mother of two children. She said: "Every woman experiences epilepsy differently in their day to day life but it is a source of worry not knowing when you might have a seizure. Pregnancy makes you actively question how best to manage your epilepsy. Our medication can help prevent seizures, but it can also potentially be harmful to the health of the baby.

"This dilemma can make the decisions around continuing to take medication during pregnancy difficult. You want to do the right thing for the baby, but it's also important to be practical. If you have a seizure there is a possibility of drowning or sustaining a serious injury, like falling down the stairs which can also harm or kill the baby.

"Many women will place priority on the advice of obstetrics and gynaecology teams but they generally have a limited understanding of epilepsy particularly as it is not their specialty. Better advice and management is needed for pregnant women with epilepsy."

The new prediction model, which has been published in the journal PLOS Medicine and online by the research team, is able to generate accurate estimates of seizure risk at any time in pregnancy in women with epilepsy who are on anti-epileptic drugs, to help inform their care.

The model uses information which can be routinely collected during an antenatal appointment, such as age at first seizure, type of seizure, seizures in the three months before pregnancy, seizures requiring hospital admission, and current dose of anti-epileptic drugs. It then processes the data to predict the likelihood of a seizures not only in pregnancy, but up to six weeks after delivery, a period with increased risks to the mother and baby.

Lead researcher Professor Shakila Thangaratinam from Queen Mary University of London said: "The EMPiRE tool is the first ever to predict the risk of seizure in pregnant women with epilepsy who are on anti-epileptic drugs. Our model gave accurate predictions regardless of the type of care the woman received, and we're now making it freely available online via a web-based calculator so that any clinician in any part of the world can use it with their patients.

"By identifying the women who are at greatest risk of seizures, we can monitor them more closely during pregnancy, labour and childbirth, or consider increasing their anti-epileptic drug dose to reduce that risk."

Dr John Allotey, research team member from Queen Mary University of London said: "Such a tool can empower women to make informed decisions on their care, including shared decision making between the woman and their healthcare professional on the level of support needed in pregnancy and after childbirth. By being aware of their risk status, women's anxiety from the unpredictable nature of seizures could be reduced, and they may also be more likely to adhere to their medication if needed."

The team of researchers developed and validated the model using datasets from the EMPiRE cohort study which looked at 560 pregnant women with epilepsy on medication from 50 hospitals in the UK.

By testing the predictive model against the data collected in the study, the team was able to show that the model accurately predicted the risk of seizures. The model discriminated well between those with and without seizures, with good agreement between predicted and observed risks across both low and high-risk women.

The freely available online calculator is aimed at general practitioners, epilepsy specialists, obstetricians, and midwives.

Ngawai Moss added: "The model will be an asset for women living with epilepsy, like me, who are looking to get pregnant or already are. It will help us make informed decisions on how we manage our epilepsy and that in itself is extremely reassuring and empowering."

The work was carried out at Barts Research Centre for Women's Health, based at Queen Mary University of London, which is funded by Barts Charity.

Victoria King, Director of Grants at Barts Charity, said: "Barts Charity invested in the Barts Research Centre for Women's Health to help research lead to tangible improvements in the health of women and their babies and this freely available tool has the potential to do just that for pregnant women with epilepsy.

"The tool can help pregnant women with epilepsy work with their healthcare team to make empowered and make informed decisions about what is right for them and their treatment during pregnancy and Barts Charity is very proud to support this."

The limitations of the model include that it is mainly applicable to high-income countries due to the source of data it is based upon, its clinical utility is restricted to thresholds above a 12 per cent risk of seizure, and the small validation cohort sample size may have affected the robustness of the external validation.
-end-
Notes to editorsAbout Queen Mary University of London

At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.

In 1785, Sir William Blizard established England's first medical school, The London Hospital Medical College, to improve the health of east London's inhabitants. Together with St Bartholomew's Medical College, founded by John Abernethy in 1843 to help those living in the City of London, these two historic institutions are the bedrock of Barts and The London School of Medicine and Dentistry.

Today, Barts and The London continues to uphold this commitment to pioneering medical education and research. Being firmly embedded within our east London community, and with an approach that is driven by the specific health needs of our diverse population, is what makes Barts and The London truly distinctive.

Our local community offer to us a window to the world, ensuring that our ground-breaking research in cancer, cardiovascular and inflammatory diseases, and population health not only dramatically improves the outcomes for patients in London, but also has a far-reaching global impact.

This is just one of the many ways in which Queen Mary is continuing to push the boundaries of teaching, research and clinical practice, and helping us to achieve the previously unthinkable.

Queen Mary University of London

Related Epilepsy Articles:

Antibodies in the brain trigger epilepsy
Certain forms of epilepsy are accompanied by inflammation of important brain regions.
Breaching the brain's defense causes epilepsy
Epileptic seizures can happen to anyone. But how do they occur and what initiates such a rapid response?
Using connectomics to understand epilepsy
Abnormalities in structural brain networks and how brain regions communicate may underlie a variety of disorders, including epilepsy, which is one focus of a two-part Special Issue on the Brain Connectome in Brain Connectivity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Epilepsy: Triangular relationship in the brain
When an epileptic seizure occurs in the brain, the nerve cells lose their usual pattern and fire in a very fast rhythm.
How concussions may lead to epilepsy
Researchers have identified a cellular response to repeated concussions that may contribute to seizures in mice like those observed following traumatic brain injury in humans.
Understanding epilepsy in pediatric tumors
A KAIST research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors.
Can medical marijuana help treat intractable epilepsy?
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis -- or medical marijuana -- for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment.
Fertility rates no different for women with epilepsy
'Myth-busting' study among women with no history of infertility finds that those with epilepsy are just as likely to become pregnant as those without.
Do women with epilepsy have similar likelihood of pregnancy?
Women with epilepsy without a history of infertility or related disorders who wanted to become pregnant were about as likely as their peers without epilepsy to become pregnant.
Hope for new treatment of severe epilepsy
Researchers at Lund University in Sweden believe they have found a method that in the future could help people suffering from epilepsy so severe that all current treatment is ineffective.
More Epilepsy News and Epilepsy Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.